香雪品牌怎么样 申请店铺

我要投票 香雪在中草药行业中的票数:315 更新时间:2025-04-20
香雪是哪个国家的品牌?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力香雪品牌出海!通过在本页面挂载香雪品牌的产品链接和联系邮箱,可以提高香雪产品曝光!跨境电商爆单神器,目前只要100元/年哦~

香雪怎么样

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://brand.waitui.com/f0447df2d.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

沃尔沃将在美国裁员多至800人,以应对关税影响

沃尔沃集团发言人当地时间4月18日表示,受美国关税政策影响,沃尔沃集团计划在未来三个月内在美国三家工厂裁员多至800人。沃尔沃集团北美公司在一份声明中说,该公司已告知员工,计划在宾夕法尼亚州、马里兰州以及弗吉尼亚州的工厂裁员550人至800人。(界面新闻)

35分钟前

敦煌网:97个国家GMV增速超100%

随着敦煌网在全球热度的持续攀升,近日平台97个国家交易额增速超过100%,其中交易额贡献TOP5国家为美国、英国、加拿大、法国、澳大利亚。单日新注册买家数量自4月15日开始连续多日同比上周增长近20倍。平台多品类GMV增长明显,其中户外装备的新买家交易量增长195%,宠物用品增长近130%,发制品激增671%,家电增长962%,安防跃升601%,健康与美容品类增长318%。(界面新闻)

35分钟前

五一假期出行预订进入高潮:酒店搜索热度翻倍,“请4休11”拼假带动长线旅游

随着五一火车票的开售,五一假期出行预订进入高潮。近日,多家在线旅游平台发布的数据显示,旅游市场的消费活力将在五一假期持续释放。携程数据显示,近一周境内酒店搜索热度环比暴涨100%,机票搜索热度飙升80%。其中,在“请4休11”拼假策略带动下,跨市住宿订单占比已突破80%,县域市场高星酒店消费反超高线城市,入境游订单同比激增173%,全民开启“假日经济新玩法”。(澎湃新闻)

35分钟前

关税政策叠加负面因素冲击美旅游业,3月赴美游客锐减12%

3月赴美外国游客数量同比下降近12%,这是自新冠疫情以来的最大降幅。《华盛顿邮报》援引美国商务部下属的国际贸易署的数据称,3月份中美洲的赴美游客同比减少24%,来自西欧国家的游客同比减少17%,其中德国游客数量的下降28%、西班牙下降25%。以上数据并不包含美国国际游客最大来源国加拿大。根据加拿大政府的初步统计数据显示,截至3月,驾车访问美国的加拿大公民人数同比下降了近32%。从美国乘飞机返回加拿大的人数下降了13.5%。美国旅游协会预测,2025年美国旅游业收入或将减少720亿美元,酒店、航空、餐饮等行业将面临连锁反应。此外,美国高盛集团预测称,在最坏情况下,入境游客和消费双双减少可能给今年美国GDP造成0.3%的损失,约合9000亿美元。(央视新闻)

35分钟前

北京文化声明:近日关于《封神2》的网络相关信息不实

据“北京文化BC”微信公众号,近日,公司发现有部分网友于互联网上发布关于公司出品电影《封神第二部:战火西岐》的不实言论,对此北京文化严正声明,关于该电影的相关信息均依北京文化发布的公告为准,其余均为不实信息。互联网并非法外之地,请大家不信谣不传谣,北京文化亦保留采取法律手段追究相关责任方法律责任的权利。

35分钟前

本页详细列出关于前列康的品牌信息,含品牌所属公司介绍,前列康所处行业的品牌地位及优势。
咨询